Supplemental material
Open access
2,393
Views
6
CrossRef citations to date
0
Altmetric
Research Paper
Hepatitis B and pertussis antibodies in 4- to 5-year-old children previously vaccinated with different hexavalent vaccines
Timo Vesikaria Department of Pediatrics, University of Tampere, Tampere, FinlandView further author information
, Jin Xub Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USAView further author information
, David R. Johnsonc Sanofi Pasteur, Swiftwater, PA, USAView further author information
, Jessie Hallb Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USAView further author information
, Tomáš Marčekd MCM Vaccine B. V., Leiden, The Netherlands
https://orcid.org/0000-0003-0920-4192View further author information
Michelle G. Goveiab Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USAView further author information
, Camilo J. Acostab Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
https://orcid.org/0000-0002-2313-3493View further author information
Andrew Wen-Tseng Leeb Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USACorrespondence[email protected]
View further author information
show allView further author information
Pages 867-874
|
Received 24 Jun 2019, Accepted 21 Sep 2019, Published online: 05 Nov 2019
Related Research Data
Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis
Source:
Elsevier BV
Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination
Source:
Elsevier BV
Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population.
Source:
Ovid Technologies (Wolters Kluwer Health)
Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy.
Source:
Elsevier BV
Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.
Source:
Elsevier BV
The value of childhood combination vaccines: From beliefs to evidence
Source:
Informa UK Limited
Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up
Source:
Springer Science and Business Media LLC
Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report.
Source:
Elsevier BV
Bordetella pertussis fimbriae (Fim): relevance for vaccines.
Source:
Informa UK Limited
A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months.
Source:
Ovid Technologies (Wolters Kluwer Health)
Nationwide vaccination: A success story in Taiwan
Source:
Elsevier BV
Long-term Protection After Hepatitis B Vaccine
Source:
Oxford University Press (OUP)
Safety and immunogenicity of a modified process hepatitis B vaccine in healthy infants.
Source:
Ovid Technologies (Wolters Kluwer Health)
Correlates of Protection Induced by Vaccination
Source:
American Society for Microbiology
A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months.
Source:
Elsevier BV
Protection against hepatitis B after 20 years
Source:
Wiley
Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.
Source:
Elsevier BV
Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response.
Source:
Elsevier BV
A 15-Year Follow-Up Study
Source:
Ovid Technologies (Wolters Kluwer Health)
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.